GlaxoSmithKline Biologicals s.a.

News and overview for GlaxoSmithKline Biologicals s.a.

AMFm subsidized malaria drugs to be delivered soon
News-Medical.Net | 18 days 13 hours 10 minutes ago
Subsidized artemisinin-based combination therapies (ACTs) under the Affordable Medicines Facility - malaria (AMFm) program will be available in select countries "in two week's time," SABC News reports. The announcement came Monday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya.


Initiative targets malaria eradication
ScientificAmerican.com | 19 days 20 hours 58 minutes ago
Next-generation vaccines are intended to move beyond the initial infection phase.D. Poland/PATH Malaria Vaccine Initiative


Prophylactic Acetaminophen Before Vaccination in Infants Reduces Vaccine Response
Medscape (free registration) | 37 days 8 minutes ago
: A new study shows that the antipyretic acetaminophen may interfere with the efficacy of vaccines and suggests that their use should not be routinely recommended.


Tylenol may weaken vaccines
Pittsburgh Post-Gazette | 38 days 12 hours 51 minutes ago
Giving babies Tylenol to prevent fever when they get childhood vaccinations may backfire and make the shots a little less effective, surprising new research suggests.


Giving babies Tylenol may blunt vaccines' effects
Seattle Times, The | 38 days 11 hours 2 minutes ago
Giving babies Tylenol to prevent fever when they get childhood vaccinations may backfire and make the shots a little less effective, surprising new research suggests. It is the first major study to tie reduced immunity to the use of fever-lowering medicines. Although the effect was small and the vast majority of kids still got enough protection from vaccines, the results make "a compelling case" against routinely giving Tylenol right after vaccination, say doctors from the U.S. Centers for Di...


Giving babies Tylenol may blunt vaccines' effects - Health/Science - News & Observer
News & Observer (Raleigh, N.C.), The | 38 days 18 hours 42 minutes ago
For a better experience using this site, please upgrade to a modern web browser.


Giving babies Tylenol may blunt vaccines' effects - Health AP - MiamiHerald.com
Miami Herald, The | 38 days 18 hours 32 minutes ago
Giving babies Tylenol to prevent fever when they get childhood vaccinations may backfire and make the shots a little less effective, surprising new research suggests.


Wire Health & Science
Sacramento Bee (Calif.), The | 38 days 18 hours 14 minutes ago
Giving babies Tylenol to prevent fever when they get childhood vaccinations may backfire and make the shots a little less effective, surprising new research suggests.


Giving babies Tylenol may blunt vaccines' effects
Tampa Tribune (Fla.), The | 38 days 3 hours 45 minutes ago
Giving babies Tylenol to prevent fever when they get childhood vaccinations may backfire and make the shots a little less effective, surprising new research suggests.


Giving babies Tylenol may blunt vaccine effects
MSNBC | 38 days 17 hours 44 minutes ago
Finding knocks common advice for parents looking to curb fever after shots





 1  2  3  4   Next >

48 Results

Sign up for Financial Planning Digest



Designed specifically for CPA personal financial planners and others interested in financial planning, Financial Planning Digest is a FREE monthly e-mail newsletter from the AICPA. It provides the most important and timely news stories to support personal financial planners. Learn more

Company Overview


Company: GlaxoSmithKline Biologicals s.a.
Industry: Biopharmaceuticals & Biotherapeutics
Website: http://www.gsk-bio.com

GlaxoSmithKline (GSK) Biologicals is the Belgium-based human vaccine research arm of GlaxoSmithKline. It is working to develop or improve vaccines to cover a range of global diseases including HIV, influenza, malaria, and tuberculosis. Much of the company's research focuses on increasing vaccine access to developing countries. GSK Biologicals has partnered with WHO and UNICEF to extend its reach into poorer regions and eliminate disease. GSK Biologicals is involved with the worldwide search for vaccinations against avian flu and malaria.


Key Numbers

Sales in U.S. Dollars (mil.) 1,640.8 (2008)
One-year % Growth in Sales 0.0 (2008)
Net Income in U.S. Dollars (mil.) 0 ()
One-year % Growth in Net Income 0.0 ()
Number of Employees 1,032 (2008)
One-year % Growth in Number of Employees 0.0 (2008)
Fiscal Year-End December